28薛文,孙正义,全东和.促红细胞生成素在大鼠脊髓缺血再灌注损伤中的表达及意义.中国脊柱脊髓杂志,2005;15(5):292-295

29 Jelkmann W, Hellwig-Burgel T. Biology of erythropoietin. Adv Exp Med Biol ,2001;502:169-187

30 Inomata Y, Hirata A, Takahashi E, Kawaji T, Fukushima M, Tanihara H. Elvated erythropoietin in vitreous with ischemic retinal diseases. Neuroreport ,2004;15(5):877-879

31 Bernaudin M, Marti HH, Roussel S, Divoux D, Nouvelot A, MacKenzie ET, Petit E. A potential role for erythropoietin in focal permanent cerebral ischemia in mice. J Cereb Blood Flow Metab ,1999;19:643-651

32 Grimm G, Wenzel A, Stanescu D, Marijana JS, Hotop S, Groszer M, Naash M, Gassmann M, Remé C. Constitutive Overexpression of Human Erythropoietin Protects the Mouse Retina against Induced But Not Inherited Retinal Degeneration. J Neuroscience ,2004;24(25):5651-5658

33 Brines M. What evidence supports use of erythropoietin as a novel neurotherapeutic. Oncology ,2002;16:79-89

34 Nissenson AR. Epoetin and cognitive function. Am J Kidney Dis ,1992;20:21-24

35 Pickett JL, Theberege DC, Brown WS, Schweitzer SU, Nissenson AR. Normalizing hematocrit in dialysis patients improves brain function. Am J Kidney Dis ,1999;33:1122-1130

36 Konishi Y, Chui DH, Hirose H, Kunishita T, Tabira T. Trophic effect of erythropoietin and other hematopoietic factors on central cholinergic neurons in vitro and in vivo. Brain Res ,1993;609:29-35

37 Campana WM, Misasi R, O'Brien JS. Identification of a neurotrophic sequence in erythropoietin. Int J Mol Med ,1998;1:235-241

38 Ruscher K, Freyer D, Karsch M, Isaev N, Megow D, Sawitzki B, Priller J, Dirnagl U, Meisel A. Erythropoietin is a paracrine mediator of ischemic tolerance in the brain: evidence from an in vitro model. J Neurosci ,2002;22:10291-10301

39 Sinor AD, Greenberg DA. Erythropoietin protects cultured cortical neurons, but not astroglia, from hypoxia and AMPA toxicity. Neurosci Lett ,2000;290:213-215

40 Yu X, Shacka JJ, Eells JB, Suarez-Quian RM, Przygodzki B, Beleslin-Cokic CS, Lin VM, Nik odem C, Hempstead B, Flanders KC, Costantini F, Noguchi CT. Erythropoietin receptor signalling is required for normal brain development. Development ,2002;192:505-516

41曾志磊,娄季宇,苗旺.促红细胞生成素对大鼠脑缺血再灌注损伤后缺血侧皮层神经元凋亡和Bcl-2表达的影响.实用神经疾病杂志,2005;8(2):31-32

42 Sakanaka M, Wen TC, Matsuda S, Masuda S, Morishita E, Nagao M, Sasaki R. In vivo evidence that erythropoietin protects neurons from ischemic damage. Proc Natl Acad Sci USA ,1998;95:4635-4640

43 Catania MA, Marciano MC, Parisi A, Sturiale A, Buemi M, Grasso G, Squadrito F, Caputi AP, Calapai G. Erythropoietin prevents cognition impairment induced by transient brain ischemia in gerbils. Eur J Pharmacol ,2002;437:147-150

44 Calapai G, Marciano MC, Corica F, Allegra A, Parisi A, Frisina N, Caputi AP, Buemi M. Erythropoietin protects against brain ischemic injury by inhibition of nitric oxide formation. Eur J Pharmacol ,2000;401:349-356

45 Brines ML, Ghezzi P, Keenan S, Agnello D, Lanerolle NC, Cerami C, Itri LM, Cerami A. Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. Proc Natl Acad Sci USA ,2000;97:10526-10531

46 Grasso G. Neuroprotective effect of recombinant human erythropoietin in experimental subrachnoid hemorrhage. J Neurosurg Sci ,2001;45:7-14

47丁建光,姜德咏.视网膜缺血-再灌注损伤的保护.国际眼科杂志,2005;5(5):1010-1015

48丁建光,姜德咏,吴荣瀚,唐朝珍,李文生.兔视网膜不同缺血时间再灌注后ERG的变化. 国际眼科杂志,2005;5(4):659-662

49牛膺筠,赵岩松,高云霞,周占宇,王红云.视网膜缺血再灌注损伤的机制及bFGF对其干预作用. 国际眼科杂志,2003;3(3):27-31

50 Koshimura K, Murakami Y, Sohmiya M, Tanaka J, Kato Y. Effects of erythropoietin on neuronal activity. J Neurochem ,1999;72:2565-2572

51 Grimm C, Wenzel A, Groszer M, Mayser H, Seeliger M, Samardzija M, Bauer C, Gassmann M, Reme CE. HIF-1-induced erythropoietin in the hypoxic retina protects against light-induced retinal degeneration. Nat Med ,2002;8:718-724

52 Tsai JC, Wu L, Worgul B, Forbes M, Cao J. Intravitreal Administration of Erythropoietin and Preservation of Retinal Ganglion Cells in an Experimental Rat Model of Glaucoma. Curr Eye Res ,2005;30(11):1025-1031

53 Layton CJ, Wood JP, Childow G, Osborne NN. Neuronal death in primary retinal cultures is related to nitric oxide production, and is inhibited by erythropoietin in a glucose-sensitive manner. J Neurochem ,2005;92(3):487-493

54 Onia S, Rex OS, Allocca M, Domenici L, Surace EM, Maguire AM, Lyubarsky A, Cellerino A, Bennett J, Auricchio A. Systemic but not intraocular Epo Gene Transfer Protects the Retina from Light-and Genetic-Induced Degeneratio. Molecule therapy ,2004;10(5):855-861

55 Jiao H, Berrada K, Yang W, Tabrizi M, Platanias LC, Yi T. Direct association with and dephosphorylation of JAK2 kinase by the SH2-domain-containing protein tyrosine phosphatase SHP-1. Mol Cell Biol ,1996;16:6985-6992

56 Campana WM, Myers RR. Erythropoietin and erythropoietin receptors in the peripheral nervous system: changes after nerve injury. FASEB J ,2001;15:1804-1806

57 Digicaylioglu M, Lipton SA. Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signalling cascades. Nature ,2001;412:641-647

58 Kennedy SG, Kandel ES, Cross TK, Hay N. Akt/Protein kinase B inhibits cell death by preventing the release of cytochrome c from mitochondria, Mol Cell Biol ,1999;19:5800-5810

59 Renzi MJ, Farrell FX, Bittner A, Galindo JE, Morton M, Trinh H. Erythropoietin induces changes in gene expression in PC12 cells. Brain Res ,2002;104:86-95

60 Viviani B, Bartesaghi S, Corsini E, Villa P, Ghezzi P, Garau A. Erythropoietin protects primary hippocampal neurons increasing the expression of brain-derived neurotrophic factor. J Neurochem ,2005;93:412-421

61 Villa P, Bigini P, Mennini T, Agnello T, La ragione T, Cagnotto A. Erythropoietin selectively attenuates cytokine production and inflammation in cerebral ischemia by targeting neuronal apoptosis. J Exp Med ,2003;198:971-975

62 Viviani B, Corsini E, Galli CL, Padovani A, Ciusani E, Marinovich M. Dying neuronal cells activate glia through the release of protease product. Glia ,2000;32:84-90

63 Ridatti D, Vacca A, Rocaro AM. Erythropoietin as an angiogenic. Eur J Invest ,2003;33:891-896

64 Tabira T, Konishi Y, Gallyas F. Neurotrophic effect of hematopoietic cytokines on cholinergic and other neurons in vitro. Int J Dev Neurosic ,1995;13:241-253

65 Shingo T, Sorokan ST, Shimazaki T. Erythropoietin regulates the in vitro and in vivo production of neuronal progenitors by mammalicm forebrain neural stem cells. J Neurosci ,2001;21:9733-9743

66吴凌,陈晓明.青光眼的视神经保护治疗.国际眼科杂志,2004;4(3):496-499

67 Jaquet K, Krause K, Tawakol-Khodai M, Geidel S, Kuck K. Erythropoietin and VEGF exhibit equal angiogenic potential. Microvasc Res ,2002;64:326-326

68 Wiessner C, Allegrini PR, Ekatodramis D, Jewell UR, Stallmach T, Gassmann M. Increased cerebral infarct volumes in polyglobulic mice overexpressing erythropoietin. J Cereb Blood Flow Metab ,2001;21:857-864

69 Erbayraktar S, Grasso G, Sfacteria A, Xie QW, Coleman T, Kreilgaard M, LTorup L, Sager T, Erbayraktar Z, Gokmen N, Yilmaz O, Ghezzi P, Villa P, Fratelli M, Casagrande S, Leist M, Helboe L, Gerwein J, Christensen S, Geist MA, Pedersen LO, Cerami-Hand C, Wuerth JP, Cerami A, Brines M. Asialoerythropoietin is a nonerythropoietic cytokine with broad neuroprotective activity in vivo. Proc Natl Acad Sci USA ,2003;100:6741-6746

70 Junk AK, Mammis A, Savitz SI, Singh M, Roth S, Malhotra S, Rosenbaum PS, Cerami A, Brines M, Rosenbaum DM. Erythropoietin administration protects retinal neurons from acute ischemia-reperfusion injury. Proc Natl Acad Sci USA ,2002;99:10659-10664

上一页  [1] [2] [3]